Home
LumiQMedia
LumiQ
-
Unlock Lab Efficiencies with an AliveDx Evaluation
The global IVD market portfolio and associated technologies are constantly evolving. AliveDx utilizes innovative technology that provides more automation and multiplex testing to drive lab workflow efficiency. Our MosaiQ® and LumiQ® solutions are designed to help transform autoimmune and allergy diagnostics performance in clinical settings, supporting productivity gains, while driving cost efficiency in a laboratory…
-
Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
-
